Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McKesson Splits CEO Into Operations & Strategy: Hammergren & Mahoney

Executive Summary

McKessonHBOC is relying on two young McKesson execs acting as a two-person CEO office to drive the integration of distribution and information businesses into a company able to link each episode of care from first patient contact to prescription dispensing.

You may also be interested in...



Ex McKesson CEO named Quidel chairman

Former Sandoz Pharma and McKesson CEO Mark Pulido has been named chairman of Quidel, the diagnostics firm announced June 2. Pulido, 51, has been a director of Quidel for two years and was most recently chairman and CEO of BenefitPoint, Inc. Pulido resigned as head of McKesson in 1999 following the disclosure of reporting irregularities associated with the wholesaler's merger with the health information firm HBOC (1"The Pink Sheet" June 28, 1999, p. 6)...

Ex McKesson CEO named Quidel chairman

Former Sandoz Pharma and McKesson CEO Mark Pulido has been named chairman of Quidel, the diagnostics firm announced June 2. Pulido, 51, has been a director of Quidel for two years and was most recently chairman and CEO of BenefitPoint, Inc. Pulido resigned as head of McKesson in 1999 following the disclosure of reporting irregularities associated with the wholesaler's merger with the health information firm HBOC (1"The Pink Sheet" June 28, 1999, p. 6)...

FDA Multi-Cycle Product Review Analysis To Begin In Fiscal 2004

FDA expects an analysis of the "root causes" of multi-cycle product reviews to begin in fiscal year 2004, Office of New Drugs Director John Jenkins, MD, said June 24 during the Biotechnology Industry Organization annual meeting in Washington, D.C

Related Content

UsernamePublicRestriction

Register

PS034406

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel